Date	Name	Title	Type	Shares Traded	Price Range
Jun 28, 2007	topper james n	Director	Buy	4,734	11.32 - 11.47
Jul 25, 2007	fhm iv lp	Beneficial Owner (10% or more)	Buy	29,700	11.35 - 11.50
Jul 25, 2007	topper james n	Director	Buy	29,700	11.35 - 11.50
Aug 1, 2009	dentzer james e	Officer	Disposition (Non Open Market)	220	11.39
Aug 24, 2007	sblendorio glenn	Director	Buy	1,000	11.39 - 11.44
Jun 29, 2007	fhm iv lp	Beneficial Owner (10% or more)	Buy	13,900	11.41 - 11.50
Jun 29, 2007	topper james n	Director	Buy	13,900	11.41 - 11.50
Jul 26, 2007	fhm iv lp	Beneficial Owner (10% or more)	Buy	4,104	11.44 - 11.50
Jul 26, 2007	topper james n	Director	Buy	4,104	11.44 - 11.50
Jul 1, 2009	dentzer james e	Officer	Disposition (Non Open Market)	220	11.45
Jun 28, 2007	fhm iv lp	Beneficial Owner (10% or more)	Buy	4,281	11.48 - 11.50
Jun 28, 2007	topper james n	Director	Buy	4,281	11.48 - 11.50
Apr 1, 2008	dentzer james e	Officer	Disposition (Non Open Market)	220	11.49
Jul 25, 2007	barris peter j	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	29,447	11.49
Jul 25, 2007	kramlich c richard	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	29,447	11.49
Jul 25, 2007	newhall charles w iii	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	29,447	11.49
Jul 25, 2007	perry mark w	Beneficial Owner (10% or more)	Acquisition (Non Open Market)	29,447	11.49
Aug 8, 2007	fhm iv lp	Beneficial Owner (10% or more)	Buy	29,600	11.50
Aug 8, 2007	topper james n	Director	Buy	29,600	11.50
Oct 14, 2008	bloch stephen m	Director	Automatic Sell	3,000	12.41
Showing 281-300 of 392 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Amicus Therapeutics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.